Immunotherapy Beyond Progression for Patients with Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Ge, X. [1 ]
Zhang, Z. [2 ]
Yan, X. [3 ]
Zhang, F. [3 ]
Yuan, F. [3 ]
Han, X. [3 ]
Huang, Z. [4 ]
Ma, J. [3 ]
Wang, L. [3 ]
Tao, H. [3 ]
Li, X. [3 ]
Zhang, S. [3 ]
Zhi, X. [1 ]
Hu, Y. [3 ]
Wang, J. [1 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Dept Oncol, Beijing, Peoples R China
[2] 78Th Grp Army Hosp Chinese PLA, Mudanjiang, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China
[4] Beigene Shanghai Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Immune checkpoint inhibitors; non-small cell lung cancer; Immunotherapy beyond progression;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P78.09
引用
收藏
页码：S641 / S642
页数：2
相关论文
共 50 条
  • [1] Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
    Ge, Xiangwei
    Zhang, Zhibo
    Zhang, Sujie
    Yuan, Fang
    Zhang, Fan
    Yan, Xiang
    Han, Xiao
    Ma, Junxun
    Wang, Lijie
    Tao, Haitao
    Li, Xiaoyan
    Zhi, Xiaoyu
    Huang, Zhiyue
    Hofman, Paul
    Prelaj, Arsela
    Banna, Giuseppe Luigi
    Mutti, Luciano
    Hu, Yi
    Wang, Jinliang
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2391 - 2400
  • [2] Clinical outcomes for immunotherapy beyond progression in patients with advanced non-small cell lung cancer
    Jia, Wenxiao
    Wang, Min
    Zhu, Hui
    Wu, Gang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Progression Patterns, Treatment, and Prognosis Beyond Resistance of Responders to Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xu, Yanjun
    Li, Hui
    Fan, Yun
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Joy
    Reckamp, Karen L.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 400 - 408
  • [5] Immune checkpoint inhibitors beyond first-line progression with prior immunotherapy in patients with advanced non-small cell lung cancer
    Xu, Manyi
    Hao, Yue
    Zeng, Xiaohong
    Si, Jinfei
    Song, Zhengbo
    [J]. JOURNAL OF THORACIC DISEASE, 2023, 15 (04) : 1648 - 1657
  • [6] Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non-small cell lung cancer
    Singhi, Eric K.
    Mott, Frank
    Worst, Michelle
    Leung, Cheuk Hong
    Lee, J. Jack
    Carter, Brett
    Presley, Carolyn J.
    Heymach, John V.
    Altan, Mehmet
    [J]. ONCOLOGY LETTERS, 2023, 25 (06)
  • [7] CLINICAL OUTCOMES OF IMMUNOTHERAPY CONTINUED BEYOND RADIOGRAPHIC PROGRESSION IN OLDER ADULTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Singhi, Eric
    Mott, Frank
    Worst, Michelle
    Leung, Cheuk Hong
    Lee, Jack
    Carter, Brett
    Presley, Carolyn
    Lewis, Jeff
    Rinsurongkawong, Waree
    Rinsurongkawong, Vadeerat
    Zhang, Jianjun
    Gibbons, Don
    Vaporciyan, Ara
    Heymach, John
    Altan, Mehmet
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A304 - A304
  • [8] Continuing EGFR inhibition beyond progression in advanced non-small cell lung cancer
    Yap, Timothy A.
    Macklin-Doherty, Aislinn
    Popat, Sanjay
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 70 : 12 - 21
  • [9] Nivolumab treatment beyond progression disease in advanced non-small cell lung cancer
    Enomoto, T.
    Tamiya, A.
    Matsumoto, K.
    Adachi, Y.
    Azuma, K.
    Inagaki, Y.
    Kouno, S.
    Taniguchi, Y.
    Saijo, N.
    Okishio, K.
    Atagi, S.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 28 - 28
  • [10] The use of immunotherapy in older patients with advanced non-small cell lung cancer
    Tagliamento, Marco
    Frelaut, Maxime
    Baldini, Capucine
    Naigeon, Marie
    Nencioni, Alessio
    Chaput, Nathalie
    Besse, Benjamin
    [J]. CANCER TREATMENT REVIEWS, 2022, 106
12345